Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.3 USD | +5.10% | +70.98% | +5.77% |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 17.64M |
---|---|---|---|---|---|
Net income 2022 | -17M | Net income 2023 | -10M | EV / Sales 2022 | - |
Net cash position 2022 | 13.25M | Net cash position 2023 | 3.84M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.65
x | P/E ratio 2023 |
-1.53
x | Employees | 11 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99% |
Latest transcript on Akari Therapeutics, Plc
1 day | +5.10% | ||
1 week | +70.98% | ||
Current month | +92.53% | ||
1 month | +106.25% | ||
3 months | +53.48% | ||
6 months | +10.00% | ||
Current year | +5.77% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 79 | 15-08-31 | |
Wendy DiCicco
DFI | Director of Finance/CFO | 56 | 23-07-18 |
Miles Nunn
CTO | Chief Tech/Sci/R&D Officer | - | 15-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Williams
BRD | Director/Board Member | 65 | 16-05-31 |
Founder | 79 | 15-08-31 | |
Director/Board Member | 61 | 23-07-04 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-12 | 3.3 | +5.10% | 44,726 |
24-06-11 | 3.14 | +24.60% | 84,692 |
24-06-10 | 2.52 | +13.00% | 70,958 |
24-06-07 | 2.23 | +1.83% | 38,851 |
24-06-06 | 2.19 | +3.27% | 16,717 |
Delayed Quote Nasdaq, June 12, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+5.77% | 37.73M | |
+16.93% | 124B | |
+17.01% | 109B | |
-7.23% | 23.84B | |
+1.98% | 22.42B | |
-14.29% | 17.5B | |
-6.79% | 16.61B | |
-37.63% | 16.43B | |
+2.17% | 13.4B | |
+24.42% | 11.47B |
- Stock Market
- Equities
- AKTX Stock